Exclusive: Alex Scharfman unpacks each of the real-life “Unicorn Tapestries” and how they inspired the look, story, ...

Eli Lilly rolled out positive Phase 2 results for lepodisiran, a therapy targeting lipoprotein(a)—that genetic party crasher ...

Pfizer is trading like it caught a cold, despite showing strong financial health post-COVID. In Q4 2024, Pfizer raked in ...

Comfortable and durable workwear is perfect for cold ORs, clinics, and outdoor weather conditions AUSTIN, TX / ACCESS ...

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

The development of long-acting drug depots represents a significant advancement in pharmaceutical technology, offering ...

Q4 2024 Earnings Call Transcript March 31, 2025 Celcuity Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, ...

Architecture firms that specialize in science and technology work, or larger companies with divisions that specialize in lab ...